City Drug House – Type 2 Diabetes Pharma Exporter to USA
City Drug House is a trusted Indian pharmaceutical exporter specializing in Type 2 Diabetes medicines for the USA and Washington markets. We provide high-quality diabetic medications manufactured under strict quality standards with reliable international shipping.
Obesema 1.7 mg Injection is a once-weekly prescription medicine used for chronic weight management in adults and adolescents (12+ years) with obesity or overweight, particularly those with related health conditions (e.g., high blood pressure, type 2 diabetes). It aids in cardiovascular risk reduction.
Key Therapeutic Applications & Benefits:
1.Weight Loss and Management: It helps reduce appetite, increases feelings of fullness, and lowers calorie intake.
Clinical trials for similar semaglutide 1.7 mg injections show average weight loss of 10-15% over 68 weeks.
2.Weight-Related Health Conditions: It helps manage obesity in patients with high blood pressure, type 2 diabetes, or high cholesterol.
3.Cardiovascular Risk Reduction: It reduces the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or cardiovascular death in adults with both obesity/overweight and established heart disease.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug House is a trusted Indian pharmaceutical exporter specializing in Type 2 Diabetes medicines for the USA and Washington markets. We provide high-quality diabetic medications manufactured under strict quality standards with reliable international shipping.
Obesema 1.7 mg Injection is a once-weekly prescription medicine used for chronic weight management in adults and adolescents (12+ years) with obesity or overweight, particularly those with related health conditions (e.g., high blood pressure, type 2 diabetes). It aids in cardiovascular risk reduction.
Key Therapeutic Applications & Benefits:
1.Weight Loss and Management: It helps reduce appetite, increases feelings of fullness, and lowers calorie intake.
Clinical trials for similar semaglutide 1.7 mg injections show average weight loss of 10-15% over 68 weeks.
2.Weight-Related Health Conditions: It helps manage obesity in patients with high blood pressure, type 2 diabetes, or high cholesterol.
3.Cardiovascular Risk Reduction: It reduces the risk of major adverse cardiovascular events (MACE) such as heart attack, stroke, or cardiovascular death in adults with both obesity/overweight and established heart disease.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
